223 related articles for article (PubMed ID: 16497598)
1. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination.
Gehricke JG; Whalen CK; Jamner LD; Wigal TL; Steinhoff K
Nicotine Tob Res; 2006 Feb; 8(1):37-47. PubMed ID: 16497598
[TBL] [Abstract][Full Text] [Related]
2. Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder.
Gehricke JG; Hong N; Whalen CK; Steinhoff K; Wigal TL
Psychol Addict Behav; 2009 Dec; 23(4):644-55. PubMed ID: 20025370
[TBL] [Abstract][Full Text] [Related]
3. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD).
Conners CK; Levin ED; Sparrow E; Hinton SC; Erhardt D; Meck WH; Rose JE; March J
Psychopharmacol Bull; 1996; 32(1):67-73. PubMed ID: 8927677
[TBL] [Abstract][Full Text] [Related]
4. OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.
Covey LS; Hu MC; Winhusen T; Weissman J; Berlin I; Nunes EV
Drug Alcohol Depend; 2010 Jul; 110(1-2):156-9. PubMed ID: 20219292
[TBL] [Abstract][Full Text] [Related]
5. Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD?
Whalen CK; Jamner LD; Henker B; Gehricke JG; King PS
Psychol Addict Behav; 2003 Dec; 17(4):332-5. PubMed ID: 14640830
[TBL] [Abstract][Full Text] [Related]
6. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
Cárdenas L; Busto UE; MacDonald A; Corrigall WA
Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
[TBL] [Abstract][Full Text] [Related]
7. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
8. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
Poltavski DV; Petros T
Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
[TBL] [Abstract][Full Text] [Related]
9. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
[TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
11. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
12. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
Corkum P; Panton R; Ironside S; Macpherson M; Williams T
J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
Levin FR; Evans SM; Brooks DJ; Garawi F
Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
15. Adults with ADHD. An overview.
Wender PH; Wolf LE; Wasserstein J
Ann N Y Acad Sci; 2001 Jun; 931():1-16. PubMed ID: 11462736
[TBL] [Abstract][Full Text] [Related]
16. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.
Lerman C; Audrain J; Tercyak K; Hawk LW; Bush A; Crystal-Mansour S; Rose C; Niaura R; Epstein LH
Nicotine Tob Res; 2001 Nov; 3(4):353-9. PubMed ID: 11694203
[TBL] [Abstract][Full Text] [Related]
17. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure.
Humfleet GL; Prochaska JJ; Mengis M; Cullen J; Muñoz R; Reus V; Hall SM
Nicotine Tob Res; 2005 Jun; 7(3):453-60. PubMed ID: 16085513
[TBL] [Abstract][Full Text] [Related]
18. Treatment of adolescent smokers with the nicotine patch.
Hanson K; Allen S; Jensen S; Hatsukami D
Nicotine Tob Res; 2003 Aug; 5(4):515-26. PubMed ID: 12959789
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
20. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
